Preclinical Services & Biomarker Discovery

About Pangaea Oncology

Pangaea Oncology is a private, revenue-generating company positioned as a precision oncology service provider and diagnostic developer in Southern Europe. Its core activities include a clinical reference laboratory offering comprehensive molecular diagnostics and companion diagnostics, and a preclinical services division (Pangaea Lab) specializing in biomarker discovery, organoid technology, and in-vitro testing. The company leverages its integrated clinical and R&D capabilities to serve both healthcare providers and pharmaceutical partners, with a strategic vision centered on data exploitation and AI to advance personalized cancer treatment.

Therapeutic Areas